Related Experiment Video

Updated: Sep 26, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

[Viral hemorrhagic fevers as a biological weapon]

Sambor Grygorczuk1, Teresa Hermanowska-Szpakowicz

  • 1Klinika Chorób Zakaznych i Neuroinfekcji Akademii Medycznej w Białymstoku.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|May 6, 2003
PubMed

Insights

Viral hemorrhagic fevers, like Ebola and Marburg viruses, are dangerous zoonoses with high fatality rates. Direct contact with infected individuals or their bodily fluids spreads these RNA viruses, necessitating strict isolation and protective measures.

Area of Science:

  • Virology
  • Epidemiology
  • Infectious Diseases

Context:

  • Viral hemorrhagic fevers (VHFs) are zoonotic diseases caused by diverse RNA viruses.
  • Ebola and Marburg viruses, particularly from West Africa, represent significant threats due to high transmissibility and up to 90% mortality.
  • These viruses have been investigated as potential bioterrorism agents.

Purpose:

  • To summarize the characteristics of viral hemorrhagic fevers, focusing on Ebola and Marburg viruses.
  • To highlight the transmission routes, symptoms, and public health implications of these diseases.
  • To underscore the limitations in current knowledge regarding Filoviridae biology and epidemiology.

Summary:

  • VHFs are zoonoses caused by RNA viruses, with Ebola and Marburg viruses posing severe risks due to rapid spread and high mortality.
  • Initial symptoms are nonspecific, progressing to severe complications including hemorrhagic issues and circulatory failure.
  • Transmission occurs via direct contact with infected persons, their bodily fluids, or cadavers; droplet spread is less common.

Impact:

  • Effective control relies on patient isolation and personal protective equipment for healthcare providers, as specific treatments are unavailable.
  • Limited understanding of Filoviridae biology and epidemiology hinders prediction of outcomes from potential bioterrorist attacks.
  • Public health strategies must address the zoonotic nature and potential for weaponization of these highly pathogenic viruses.

More Related Videos

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

Related Concept Videos

Viral Recombination00:57

Viral Recombination

Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Introduction to Virus01:28

Introduction to Virus

Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...